Valuation : genedrive plc

Market Cap 2.09Cr 2.83Cr 2.44Cr 2.29Cr 3.92Cr 269.11Cr 3.95Cr 27Cr 11Cr 136.46Cr 11Cr 10Cr 451.84Cr P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 1.97Cr 2.67Cr 2.3Cr 2.16Cr 3.7Cr 253.87Cr 3.73Cr 26Cr 9.94Cr 128.73Cr 10Cr 9.8Cr 426.26Cr EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.5%
Yield 2024 *
-
Yield 2025 -
1 day+5.66%
1 week+7.69%
Current month+40.00%
1 month+33.33%
3 months+7.69%
6 months+36.59%
Current year+60.00%
1 week 1.25
Extreme 1.25
1.4
1 month 1
Extreme 1
1.4
Current year 0.75
Extreme 0.75
1.5
1 year 0.19
Extreme 0.19
1.5
3 years 0.19
Extreme 0.19
14.8
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 06/08/2024
Director of Finance/CFO 48 07/04/2022
Director TitleAgeSince
Director/Board Member 69 09/04/2018
Director/Board Member 52 22/08/2018
Director/Board Member 56 11/09/2023
Date Insider Type Main position Quantity % Market Cap. Importance
20/12/24 Buy

Chief Financial Officer

10,00,000 0.1841%
20/12/24 Free 4,00,000 0.0736%
20/12/24 Buy

Chief Executive Officer

11,35,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
+5.66%+7.69%+133.33%-87.83% 3.05Cr
-1.70%+2.51%+22.46%-33.97% 1.82TCr
-2.86%-2.11%-37.25%+53.12% 164.76Cr
-2.10%-0.41%-48.92%-82.48% 101.08Cr
-1.74%-1.29%-24.71%+17.42% 96Cr
-0.05%-0.16%+59.40%-6.00% 78Cr
+0.18%-2.17%-34.67%-47.78% 67Cr
+5.81%+5.70%-38.29%-49.26% 57Cr
-0.27%+0.54%-38.14%-36.64% 46Cr
-0.56%-2.29%+79.63%+48.40% 44Cr
Average +0.24%+0.49%+7.28%-22.50% 247.5Cr
Weighted average by Cap. -1.46%+1.38%+11.99%-26.64%

Financials

2024 2025
Net sales 5L 7L 6L 5L 9L 6.46Cr 9L 65.04L 25.3L 3.28Cr 25.49L 24.94L 11Cr 10L 12.93L 11.13L 10.45L 17.92L 12Cr 18.05L 1.24Cr 48.18L 6.24Cr 48.54L 47.48L 21Cr
Net income -70.75L -95.87L -82.54L -77.51L -1.33Cr -91Cr -1.34Cr -9.18Cr -3.57Cr -46Cr -3.6Cr -3.52Cr -153.16Cr -52.31L -70.88L -61.03L -57.31L -98.27L -67Cr -98.97L -6.79Cr -2.64Cr -34Cr -2.66Cr -2.6Cr -113.24Cr
Net Debt -51.69L -70.04L -60.31L -56.63L -97.1L -67Cr -97.8L -6.71Cr -2.61Cr -34Cr -2.63Cr -2.57Cr -111.9Cr -11.82L -16.02L -13.79L -12.95L -22.2L -15Cr -22.36L -1.53Cr -59.7L -7.73Cr -60.14L -58.83L -26Cr
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
28/26/28 GBX 1.400 +5.66% 49,42,826
27/26/27 GBX 1.325 -.--% 7,77,076
26/26/26 GBX 1.325 +1.92% 8,64,851
25/26/25 GBX 1.300 -5.80% 31,25,127

Annual profits - Rate of surprise